all report title image

VYNDAQEL MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Vyndaqel Market, By Indication (Wild-type transthyretin-mediated amyloidosis cardiomyopathy (ATTR-CM, wild-type), Hereditary transthyretin-mediated amyloidosis cardiomyopathy (ATTR-CM, variant), and Transthyretin-mediated amyloidosis polyneuropathy (ATTR-PN/FAP) ), By Strength ( 20 mg and 61 mg), By Payer (Public, Private, and Self-pay/Out-of-pocket), By Distribution Channel ( Hospital pharmacies, Specialty/Online pharmacies, and Retail pharmacies), By End User ( Hospitals, Cardiac Amyloidosis Centers, Ambulatory Surgical Centers, and Homecare Settings), By Age group ( Adults (≥18 yrs) and Elderly (≥65 yrs)), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In: 01 Apr, 2026
  • Code: CMI8971
  • Page number: 160
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

 Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Vyndaqel Market, By Indication
      • Global Vyndaqel Market, By Strength
      • Global Vyndaqel Market, By Payer
      • Global Vyndaqel Market, By Distribution Channel
      • Global Vyndaqel Market, By End User
      • Global Vyndaqel Market, By Age group
      • Global Vyndaqel Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Vyndaqel Market, By Indication, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Wild-type transthyretin-mediated amyloidosis cardiomyopathy (ATTR-CM, wild-type)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Hereditary transthyretin-mediated amyloidosis cardiomyopathy (ATTR-CM, variant)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Transthyretin-mediated amyloidosis polyneuropathy (ATTR-PN/FAP)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  5. Global Vyndaqel Market, By Strength, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • 20 mg
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • 61 mg
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  6. Global Vyndaqel Market, By Payer, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Public
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Private
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Self-pay/Out-of-pocket
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  7. Global Vyndaqel Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospital pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Specialty/Online pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retail pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Vyndaqel Market, By End User, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Cardiac Amyloidosis Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Homecare Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  9. Global Vyndaqel Market, By Age group, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Adults (≥18 yrs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Elderly (≥65 yrs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  10. Global Vyndaqel Market, By Region, 2021 - 2033, Value (USD Bn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Payer, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Age group, 2021 - 2033, Value (USD Bn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
        • South Africa
        • North Africa
        • Central Africa
  11. Competitive Landscape

    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  12. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  13. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on ‘Vyndaqel Market' - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.